Current anti-obesity pharmacotherapy includes 5 FDA-approved medications: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide (Table 2), as well as phentermine, which is approved only for short term use
This oral peptide is particularly effective for individuals with: Excess visceral (abdominal) fat Metabolic syndrome or insulin resistance Age-related NAD+ decline Fat loss goals while preserving muscle mass GLP-1 users who want to offset muscle loss Its also ideal for people who: Prefer oral therapy over injections Travel frequently and need convenience Want a well-tolerated fat loss support with no stimulant effects How It Compares to Other Peptides Side Effects and Safety To date, no harmful side effects have been reported with oral 5-Amino-1MQ in either animal studies or clinical use
If not, you can order a urinary MMA (uMMA) test from Dr
A reduction in the mRNA level of inflammatory mediators (iNOS, IL-6, IFN-, and TNF-) and increased expression of HSP 70 and 90 and antioxidant proteins such as HO-1, NQO-1, glutathione reductase, glutathione peroxidase 2, and GST-pi were observed (Park et al., 2020)
At a branch Visit your local Wells Fargo branch and speak with a representative to get started
Exclusion criteria were: (a) in-vitro RCTs
